Literature DB >> 11851894

Increased mortality rate and not impaired ribosomal biogenesis is responsible for proliferative defect in dyskeratosis congenita cell lines.

Lorenzo Montanaro1, Alessandra Chillà, Davide Trerè, Annalisa Pession, Marzia Govoni, Pier Luigi Tazzari, Massimo Derenzini.   

Abstract

X-linked dyskeratosis congenita is a rare inherited disorder mainly characterized by progressive changes in proliferating epidermal, mucosal, and bone marrow tissues that commonly emerge after 10 y of life. It is caused by mutations of the DKC1 gene, which codes for dyskerin, a protein that may play a role in ribosomal biogenesis. In order to verify whether the defects of proliferating tissues observed in dyskeratosis congenita are due to an altered ribosome synthesis, we studied ribosomal biogenesis in relation to cell proliferation in two lymphoblastoid cell lines from dyskeratosis congenita patients and in one control line. We observed that in the dyskeratosis congenita cell lines the rRNA transcription and maturation and proliferative capability remained unimpaired. Increasing the number of cell cycles, however, leads to a steep rise in the apoptotic fraction of dyskeratosis congenita cells, which is not observed in controls. These findings demonstrate that whereas dyskeratosis congenita cell lines do not display proliferation defects, they do show progressively increasing levels of apoptosis in relation to the number of cell divisions. This concept is consistent with (i) the delayed onset of dyskeratosis congenita proliferating-tissue defects, which do not emerge during embrional development as would be expected with ribosomal biogenesis alterations, and (ii) with the increasing severity of the proliferating-tissue defects over time.

Entities:  

Mesh:

Year:  2002        PMID: 11851894     DOI: 10.1046/j.0022-202x.2001.01634.x

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  11 in total

Review 1.  When ribosomes go bad: diseases of ribosome biogenesis.

Authors:  Emily F Freed; Franziska Bleichert; Laura M Dutca; Susan J Baserga
Journal:  Mol Biosyst       Date:  2010-01-11

2.  Dyskerin is required for tumor cell growth through mechanisms that are independent of its role in telomerase and only partially related to its function in precursor rRNA processing.

Authors:  Faizan Alawi; Ping Lin
Journal:  Mol Carcinog       Date:  2010-12-10       Impact factor: 4.784

Review 3.  Dyskeratosis congenita, stem cells and telomeres.

Authors:  Michael Kirwan; Inderjeet Dokal
Journal:  Biochim Biophys Acta       Date:  2009-02-07

4.  Telomerase RNA deficiency in peripheral blood mononuclear cells in X-linked dyskeratosis congenita.

Authors:  Judy M Y Wong; Mouhammed J Kyasa; Laura Hutchins; Kathleen Collins
Journal:  Hum Genet       Date:  2004-09-03       Impact factor: 4.132

5.  Enhanced telomere shortening in transformed lymphoblasts from patients with X linked dyskeratosis.

Authors:  L Montanaro; P L Tazzari; M Derenzini
Journal:  J Clin Pathol       Date:  2003-08       Impact factor: 3.411

6.  POT of gold: modeling dyskeratosis congenita in the mouse.

Authors:  Chantal Autexier
Journal:  Genes Dev       Date:  2008-07-01       Impact factor: 11.361

7.  Mutations linked to dyskeratosis congenita cause changes in the structural equilibrium in telomerase RNA.

Authors:  Carla A Theimer; L David Finger; Lukas Trantirek; Juli Feigon
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-13       Impact factor: 11.205

8.  YNMG tetraloop formation by a dyskeratosis congenita mutation in human telomerase RNA.

Authors:  Carla A Theimer; L David Finger; Juli Feigon
Journal:  RNA       Date:  2003-12       Impact factor: 4.942

Review 9.  Further delineation of the congenital form of X-linked dyskeratosis congenita (Hoyeraal-Hreidarsson syndrome).

Authors:  Yves Sznajer; Clarisse Baumann; Albert David; Hubert Journel; Didier Lacombe; Yves Perel; Pascale Blouin; Jean-François Segura; Jean-Pierre Cezard; Michel Peuchmaur; Tomy Vulliamy; Inderjeet Dokal; Alain Verloes
Journal:  Eur J Pediatr       Date:  2003-09-30       Impact factor: 3.183

10.  Expression profile of telomere-associated genes in multiple myeloma.

Authors:  Rafael Díaz de la Guardia; Purificación Catalina; Julieta Panero; Carolina Elosua; Andrés Pulgarin; María Belén López; Verónica Ayllón; Gertrudis Ligero; Irma Slavutsky; Paola E Leone
Journal:  J Cell Mol Med       Date:  2012-12       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.